|
Lesch, K.; Bengel, D.; Heils, A.; Sabol, S. Z.; Greenberg, B. D.; Petri, S.; Clemens, R.; M¸ller, J. B.; Hamer, D. H.; Murphy, D. L. (1996). "Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region". Science 274: 1527ñ31.
Caspi, A.; Sugden, K.; Moffitt, T. E.; Taylor, A.; Craig, I. W.; Harrington, W.; McClay, J.; Mill, J.; Martin, J.; Braithwaite, A.; Poulton, R. (2003). "Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene". Science 301: 386ñ89.
Caspi N, Modai I, Barak P, Waisbourd A, Zbarsky H, Hirschmann S, Ritsner M. (2001 Mar). "Pindolol augmentation in aggressive schizophrenic patients: a double-blind crossover randomized study". Int Clin Psychopharmacol. 16(2): 111-5.
Crockett, M. J.; Clark, L.; Tabibnia, G.; Lieberman, M. D.; Robbins, T. W. (June 2008). "Serotonin modulates behavioral reactions to unfairness". Science (journal) 320 (5884): 1739.
Audero, Enrica; Coppi, Elisabetta; Mlinar, Boris; Rossetti, Tiziana; Caprioli, Antonio; Al Banchaabouchi, Mumna; Corradetti, Renato; Gross, Cornelius (2008). "Sporadic Autonomic Dysregulation and Death Associated with Excessive Serotonin Autoinhibition". Science 321: 130ñ133.
Lesurtel, M. et al. (2006). "Platelet-derived serotonin mediates liver regeneration". Science 312 (5770): 104ñ7.
White, KJ; Walline, CC; Barker, EL. Serotonin transporters: implications for antidepressant drug development. Aaps J. 2005;7:E421ñ33.
Blakely, RD; De Felice, LJ; Hartzell, HC. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol. 1994;196:263ñ81.
Shaskan, EG; Snyder, SH. Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther. 1970;175:404ñ18.
Ramamoorthy, S; Bauman, AL; Moore, KR; Han, H; Yang-Feng, T; Chang, AS, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A. 1993;90:2542ñ6.
Thakker, DR; Natt, F; Husken, D; van der Putten, H; Maier, R; Hoyer, D, et al. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol Psychiatry. 2005;10(782):9ñ14.
DeVane, CL. Metabolism and pharmacokinetics of selective serotonin reuptake inhibitors. Cell Mol Neurobiol. 1999;19:443ñ66.
Baumann, P. Pharmacokinetic-pharmacodynamic relationship of the selective serotonin reuptake inhibitors. Clin Pharmacokinet. 1996;31:444ñ69.
Feng, N; Mo, B; Johnson, PL; Orchinik, M; Lowry, CA; Renner, KJ. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res. 2005;1063:69ñ76.
Pan, Y; Gembom, E; Peng, W; Lesch, KP; Mossner, R; Simantov, R. Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res. 2001;126:125ñ9.
Ravary, A; Muzerelle, A; Darmon, M; Murphy, DL; Moessner, R; Lesch, KP, et al. Abnormal trafficking and subcellular localization of an N-terminally truncated serotonin transporter protein. Eur J Neurosci. 2001;13:1349ñ62.
Reyes-Haro, D; Garcia-Alcocer, G; Miledi, R; Garcia-Colunga, J. Uptake of serotonin by adult rat corpus callosum is partially reduced by common antidepressants. J Neurosci Res. 2003;74:97ñ102.
Bengel, D; Murphy, DL; Andrews, AM; Wichems, CH; Feltner, D; Heils, A, et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine (ìEcstasyî) in serotonin transporter-deficient mice. Mol Pharmacol. 1998;53:649ñ55.
Austin, MC; Bradley, CC; Mann, JJ; Blakely, RD. Expression of serotonin transporter messenger RNA in the human brain. J Neurochem. 1994;62:2362ñ7.
Barker, EL; Perlman, MA; Adkins, EM; Houlihan, WJ; Pristupa, ZB; Niznik, HB, et al. High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis. An aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem. 1998;273:19459ñ68.
Schrˆder P, Abele C, Gohr P, Stuhlfauth-Roisch U, Grosse W. (1999). "Latest on enzymology of serotonin biosynthesis in walnut seeds". Adv Exp Med Biol. 467: 637-644.
Benmansour, Saloua et al., Effects of Chronic Antidepressant Treatments on Serotonin Transporter Function, Density, and mRNA Level. Journal of Neuroscience, 1999, 19(23):10494-10501.
Farde, Lars; and Borg, Jacqueline; Section of psychiatry at Karolinska Institutet in Stockholm, Sweden 2003
Isbister, G. K.; Bowe, S. J.; Dawson, A.; Whyte, I. M. (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". J. Toxicol. Clin. Toxicol. 42 (3): 277ñ85.
Rapport MM, Green AA, Page IH. Serum vasoconstriction (serotonin), IV: isolation and characterization. J Biol Chem 1948; 176:1243ñ51
Sporer KA. The serotonin syndrome. Implicated drugs, pathophysiology and management. Drug Saf 1995; 13:94ñ104
Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148:705ñ13
Oates JA, Sjostrand U. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 1960; 10:1076ñ8
Insel TR, Roy BF, Cohen RM, Murphy DL. Possible development of the serotonin syndrome in man. Am J Psychiatry 1982; 139:954ñ5
Gillman PK. Serotonin syndrome: history and risk. Fundam Clin Pharmacol 1998; 12:482ñ91.
Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100ñ9.
Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 1997; 17:208ñ21
Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin Syndrome. Neurology 1995; 45:219ñ23
Isbister GK, Dawson AH, Whyte IM. Comment: serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 2001; 35:1674ñ5
Isbister GK, Downes F, Whyte IM. Olanzapine and serotonin toxicity. Psychiatry Clin Neurosci 2003; 57:244.
Richelson E, Souder T. Binding of antipsychotic drugs to human brain receptors: Focus on newer generation compounds. Life Sci 2000; 68:29ñ39
Haslett CD, Kumar S. Can olanzapine be implicated in causing serotonin syndrome? Psychiatry Clin Neurosci 2002; 56:533ñ5
Duggal HS, Fetchko J. Serotonin syndrome and atypical antipsychotics. Am J Psychiatry 2002; 159:672ñ3
Demers JCM. Serotonin syndrome induced by fluvoxamine and mirtazapine. Ann Pharmacother 2001; 35:1217ñ20
Ubogu EE, Katirji B. Mirtazapine-induced serotonin syndrome. Clin Neuropharmacol 2003; 26:54ñ7
Isbister GK, Dawson A, Whyte IM. Citalopram overdose, serotonin toxicity, or neuroleptic malignant syndrome? Can J Psychiatry 2001; 46:657ñ9
Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ. The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 1998; 248:96ñ103
Radomski JW, Dursun SM, Reveley MAKSP. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 1999; 55:218ñ24.
Isbister GK, Hackett LP, Dawson A, Whyte IM, Smith AJ. Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. Br J Clin Pharmacol 2003; in press.
Power BM, Pinder M, Hackett LP, Ilett KF. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care 1995; 23:499ñ502
Fraser J, South M. Life-threatening fluvoxamine overdose in a 4-year-old child. Intensive Care Med 1999; 25:548.
Whyte IM, Dawson AH. Redefining the serotonin syndrome. J Toxicol Clin Toxicol 2002; 40:668ñ9.
Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Self-poisoning in Newcastle, 1987ñ1992. Med J Aust 1995; 162:190ñ3
Whyte IM, Buckley NA, Dawson AH. Data collection in clinical toxicology: are there too many variables? J Toxicol Clin Toxicol 2002; 40:223ñ30
Buckley NA, Whyte IM, Dawson AH, Reith DA. Preformatted admission charts for poisoning admissions facilitate clinical assessment and research. Ann Emerg Med 1999; 34:476ñ82
SAS [8.2]. Cary NC, SAS Institute, 2001.
Breiman L, Friedman J, Olshen R, Stone C. Classification and regression trees. Pacific Grove, Wadsworth, 1984.
Isbister GK, Dawson A, Whyte IM. Comment: serotonin syndrome and 5-HT2A antagonism. Ann Pharmacother 2001; 35:1143ñ4
Whyte I. Serotonin syndrome complicating treatment of recurrent depression. Curr Therapeut 1999; 40:6ñ7.
Baloh RW, Dietz J, Spooner JW. Myoclonus and ocular oscillations induced by L-tryptophan. Ann Neurol 1982; 11:95ñ7
Prior FH, Isbister GK, Dawson AH, Whyte IM. Serotonin toxicity with therapeutic doses of dexamphetamine and venlafaxine [letter]. Med J Aust 2002; 176:240ñ1.
Johnson, D. J.; Sanderson, H.; Brain, R. A.; Wilson, C. J.; Solomon, K. R. (2007). "Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae". Ecotoxicol. Environ. Saf. 67 (1): 128ñ39.
McGowan, K.; Kane, A.; Asarkof, N. et al. (1983). "Entamoeba histolytica causes intestinal secretion: role of serotonin". Science 221 (4612): 762ñ4.
Acharya, D. P.; Sen, M. R.; Sen, P. C. (1989). "Effect of exogenous 5-hydroxytryptamine on pathogenicity of Entamoeba histolytica in experimental animals". Indian J. Exp. Biol. 27 (8): 718ñ20.
|
